Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44.

Niehrs A, Garcia-Beltran WF, Norman PJ, Watson GM, Hölzemer A, Chapel A, Richert L, Pommerening-Röser A, Körner C, Ozawa M, Martrus G, Rossjohn J, Lee JH, Berry R, Carrington M, Altfeld M.

Nat Immunol. 2019 Sep;20(9):1129-1137. doi: 10.1038/s41590-019-0448-4. Epub 2019 Jul 29.

PMID:
31358998
2.

Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.

François S, Usunier B, Forgue-Lafitte ME, L'Homme B, Benderitter M, Douay L, Gorin NC, Larsen AK, Chapel A.

Stem Cells Transl Med. 2019 Mar;8(3):285-300. doi: 10.1002/sctm.18-0117. Epub 2018 Nov 19.

3.

Author Correction: Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

François S, Eder V, Belmokhtar K, Machet MC, Douay L, Gorin NC, Benderitter M, Chapel A.

Sci Rep. 2018 Apr 11;8(1):6050. doi: 10.1038/s41598-018-23594-x.

4.

Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

François S, Eder V, Belmokhtar K, Machet MC, Douay L, Gorin NC, Benderitter M, Chapel A.

Sci Rep. 2017 Jun 27;7(1):4272. doi: 10.1038/s41598-017-04496-w. Erratum in: Sci Rep. 2018 Apr 11;8(1):6050.

5.

Peptide-specific engagement of the activating NK cell receptor KIR2DS1.

Chapel A, Garcia-Beltran WF, Hölzemer A, Ziegler M, Lunemann S, Martrus G, Altfeld M.

Sci Rep. 2017 May 25;7(1):2414. doi: 10.1038/s41598-017-02449-x.

6.

TLR7-mediated activation of XBP1 correlates with the IFNα production in humans.

Beisel C, Ziegler S, Martrus Zapater G, Chapel A, Griesbeck M, Hildebrandt H, Lohse AW, Altfeld M.

Cytokine. 2017 Jun;94:55-58. doi: 10.1016/j.cyto.2017.04.006. Epub 2017 Apr 10.

PMID:
28408069
7.

Evaluation of two VIDAS ®prototypes for detecting anti-HEV IgG.

Abravanel F, Goutagny N, Perret C, Lhomme S, Vischi F, Aversenq A, Chapel A, Dehainault N, Piga N, Dupret-Carruel J, Izopet J.

J Clin Virol. 2017 Apr;89:46-50. doi: 10.1016/j.jcv.2017.02.009. Epub 2017 Feb 24.

PMID:
28249234
8.

Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

Lunemann S, Martrus G, Hölzemer A, Chapel A, Ziegler M, Körner C, Garcia Beltran W, Carrington M, Wedemeyer H, Altfeld M.

J Hepatol. 2016 Aug;65(2):252-8. doi: 10.1016/j.jhep.2016.03.016. Epub 2016 Apr 4.

9.

Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16.

Gunn B, Schneider J, Shansab M, Bastian AR, Fahrbach K, Smith A 4th, Mahan A, Karim M, Licht A, Zvonar I, Tedesco J, Anderson M, Chapel A, Suscovich T, Malaspina D, Streeck H, Walker BD, Kim A, Lauer G, Altfeld M, Pillai S, Szleifer I, Kelleher NL, Kiser PF, Hope TJ, Alter G.

Mucosal Immunol. 2016 Nov;9(6):1549-1558. doi: 10.1038/mi.2016.8. Epub 2016 Mar 9.

10.

Resistant Starch Alters the Microbiota-Gut Brain Axis: Implications for Dietary Modulation of Behavior.

Lyte M, Chapel A, Lyte JM, Ai Y, Proctor A, Jane JL, Phillips GJ.

PLoS One. 2016 Jan 8;11(1):e0146406. doi: 10.1371/journal.pone.0146406. eCollection 2016.

11.

Management of fibrosis: the mesenchymal stromal cells breakthrough.

Usunier B, Benderitter M, Tamarat R, Chapel A.

Stem Cells Int. 2014;2014:340257. doi: 10.1155/2014/340257. Epub 2014 Jul 14. Review.

12.

Generation of multipotent early lymphoid progenitors from human embryonic stem cells.

Larbi A, Mitjavila-Garcia MT, Flamant S, Valogne Y, Clay D, Usunier B, l'Homme B, Féraud O, Casal I, Gobbo E, Divers D, Chapel A, Turhan AG, Bennaceur-Griscelli A, Haddad R.

Stem Cells Dev. 2014 Dec 15;23(24):2983-95. doi: 10.1089/scd.2014.0171.

PMID:
24955741
13.

Long-Term Quantitative Biodistribution and Side Effects of Human Mesenchymal Stem Cells (hMSCs) Engraftment in NOD/SCID Mice following Irradiation.

François S, Usunier B, Douay L, Benderitter M, Chapel A.

Stem Cells Int. 2014;2014:939275. doi: 10.1155/2014/939275. Epub 2014 Feb 11.

15.

Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects.

Francois S, Mouiseddine M, Allenet-Lepage B, Voswinkel J, Douay L, Benderitter M, Chapel A.

Biomed Res Int. 2013;2013:151679. doi: 10.1155/2013/151679. Epub 2013 Nov 28.

16.
17.

Stem cell therapies for the treatment of radiation-induced normal tissue side effects.

Benderitter M, Caviggioli F, Chapel A, Coppes RP, Guha C, Klinger M, Malard O, Stewart F, Tamarat R, van Luijk P, Limoli CL.

Antioxid Redox Signal. 2014 Jul 10;21(2):338-55. doi: 10.1089/ars.2013.5652. Epub 2014 Feb 3. Review.

18.

Fifteen years of preclinical and clinical experiences about biotherapy treatment of lesions induced by accidental irradiation and radiotherapy.

Chapel A, Francois S, Douay L, Benderitter M, Voswinkel J.

World J Stem Cells. 2013 Jul 26;5(3):68-72. doi: 10.4252/wjsc.v5.i3.68.

19.

Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells.

Voswinkel J, Francois S, Gorin NC, Chapel A.

Immunol Res. 2013 Jul;56(2-3):241-8. doi: 10.1007/s12026-013-8397-8. Review.

PMID:
23564182
20.

An extended proteome map of the lysosomal membrane reveals novel potential transporters.

Chapel A, Kieffer-Jaquinod S, Sagné C, Verdon Q, Ivaldi C, Mellal M, Thirion J, Jadot M, Bruley C, Garin J, Gasnier B, Journet A.

Mol Cell Proteomics. 2013 Jun;12(6):1572-88. doi: 10.1074/mcp.M112.021980. Epub 2013 Feb 24.

21.

Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.

Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A.

Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92. doi: 10.1007/s12016-012-8347-6. Review.

PMID:
23296948
22.

Mesenchymal stromal cell therapy to repair radiation-induced intestinal damage: implications for treatment of abdominopelvic malignancy.

Chapel A.

Cytotherapy. 2012 Nov;14(10):1157-8. doi: 10.3109/14653249.2012.730321. No abstract available.

PMID:
23066783
23.

[Mesenchymal stem cells and rheumatism. State of the art].

Voswinkel J, Chapel A.

Z Rheumatol. 2012 Sep;71(7):619-23. doi: 10.1007/s00393-011-0950-z. German.

PMID:
22825552
24.

The HOXB4 homeoprotein promotes the ex vivo enrichment of functional human embryonic stem cell-derived NK cells.

Larbi A, Gombert JM, Auvray C, l'Homme B, Magniez A, Féraud O, Coulombel L, Chapel A, Mitjavila-Garcia MT, Turhan AG, Haddad R, Bennaceur-Griscelli A.

PLoS One. 2012;7(6):e39514. doi: 10.1371/journal.pone.0039514. Epub 2012 Jun 27.

25.

Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model.

Kobari L, Yates F, Oudrhiri N, Francina A, Kiger L, Mazurier C, Rouzbeh S, El-Nemer W, Hebert N, Giarratana MC, François S, Chapel A, Lapillonne H, Luton D, Bennaceur-Griscelli A, Douay L.

Haematologica. 2012 Dec;97(12):1795-803. doi: 10.3324/haematol.2011.055566. Epub 2012 Jun 24.

26.

Proteomic analysis of S-acylated proteins in human B cells reveals palmitoylation of the immune regulators CD20 and CD23.

Ivaldi C, Martin BR, Kieffer-Jaquinod S, Chapel A, Levade T, Garin J, Journet A.

PLoS One. 2012;7(5):e37187. doi: 10.1371/journal.pone.0037187. Epub 2012 May 17.

27.

Intravenous human mesenchymal stem cells transplantation in NOD/SCID mice preserve liver integrity of irradiation damage.

Mouiseddine M, François S, Souidi M, Chapel A.

Methods Mol Biol. 2012;826:179-88. doi: 10.1007/978-1-61779-468-1_15.

PMID:
22167649
28.

Investigating the macropinocytic proteome of Dictyostelium amoebae by high-resolution mass spectrometry.

Journet A, Klein G, Brugière S, Vandenbrouck Y, Chapel A, Kieffer S, Bruley C, Masselon C, Aubry L.

Proteomics. 2012 Jan;12(2):241-5. doi: 10.1002/pmic.201100313. Epub 2011 Dec 20.

PMID:
22120990
29.

Early lesions induced in rat colon epithelium by N-methyl-N'-nitro-N-nitrosoguanidine.

Che TC, François S, Bouchet S, Chapel A, Forgue-Lafitte ME.

Tissue Cell. 2010 Jun;42(3):190-4. doi: 10.1016/j.tice.2010.04.002. Epub 2010 May 20.

PMID:
20493508
30.

New emerging concepts in the medical management of local radiation injury.

Benderitter M, Gourmelon P, Bey E, Chapel A, Clairand I, Prat M, Lataillade JJ.

Health Phys. 2010 Jun;98(6):851-7. doi: 10.1097/HP.0b013e3181c9f79a.

PMID:
20445393
31.

Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis.

Sémont A, Mouiseddine M, François A, Demarquay C, Mathieu N, Chapel A, Saché A, Thierry D, Laloi P, Gourmelon P.

Cell Death Differ. 2010 Jun;17(6):952-61. doi: 10.1038/cdd.2009.187. Epub 2009 Dec 18.

32.

Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities.

Vauchez K, Marolleau JP, Schmid M, Khattar P, Chapel A, Catelain C, Lecourt S, Larghéro J, Fiszman M, Vilquin JT.

Mol Ther. 2009 Nov;17(11):1948-58. doi: 10.1038/mt.2009.204. Epub 2009 Sep 8.

33.

The pattern of procalcitonin in primary total hip and knee arthroplasty and its implication in periprosthetic infection.

Ali S, Christie A, Chapel A.

J Clin Med Res. 2009 Jun;1(2):90-4. doi: 10.4021/jocmr2009.04.1236. Epub 2009 May 20.

34.

Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.

Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin NC, Lopez M, Thierry D, Fouillard L, Chapel A.

Int J Lab Hematol. 2009 Feb;31(1):9-19. doi: 10.1111/j.1751-553X.2007.00997.x.

PMID:
19143868
35.

Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.

Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, Gorin NC, Fouillard L.

Cell Immunol. 2008 May-Jun;253(1-2):16-22. doi: 10.1016/j.cellimm.2008.06.002. Epub 2008 Jul 18.

PMID:
18639869
36.

Affinity purification of soluble lysosomal proteins for mass spectrometric identification.

Jaquinod SK, Chapel A, Garin J, Journet A.

Methods Mol Biol. 2008;432:243-58. doi: 10.1007/978-1-59745-028-7_17.

PMID:
18370023
37.

Mesenchymal stem cell abnormalities in patients with multiple myeloma.

Garderet L, Mazurier C, Chapel A, Ernou I, Boutin L, Holy X, Gorin NC, Lopez M, Doucet C, Lataillade JJ.

Leuk Lymphoma. 2007 Oct;48(10):2032-41.

PMID:
17917971
38.

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy.

Lataillade JJ, Doucet C, Bey E, Carsin H, Huet C, Clairand I, Bottollier-Depois JF, Chapel A, Ernou I, Gourven M, Boutin L, Hayden A, Carcamo C, Buglova E, Joussemet M, de Revel T, Gourmelon P.

Regen Med. 2007 Sep;2(5):785-94.

39.

Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model.

Mouiseddine M, François S, Semont A, Sache A, Allenet B, Mathieu N, Frick J, Thierry D, Chapel A.

Br J Radiol. 2007 Sep;80 Spec No 1:S49-55.

PMID:
17704326
40.

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.

Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.

Transplantation. 2007 Jul 27;84(2):231-7.

PMID:
17667815
41.

Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells.

Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, Sensebé L, Zhang Y, Gorin NC, Thierry D, Fouillard L.

Gene Expr. 2007;13(4-5):217-26.

42.

Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.

Fouillard L, Chapel A, Bories D, Bouchet S, Costa JM, Rouard H, Hervé P, Gourmelon P, Thierry D, Lopez M, Gorin NC.

Leukemia. 2007 Mar;21(3):568-70. Epub 2007 Jan 25. No abstract available.

PMID:
17252011
43.

Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury.

Sémont A, François S, Mouiseddine M, François A, Saché A, Frick J, Thierry D, Chapel A.

Adv Exp Med Biol. 2006;585:19-30.

PMID:
17120774
44.

Biochemical characterization and lysosomal localization of the mannose-6-phosphate protein p76 (hypothetical protein LOC196463).

Jensen AG, Chemali M, Chapel A, Kieffer-Jaquinod S, Jadot M, Garin J, Journet A.

Biochem J. 2007 Mar 15;402(3):449-58.

45.

Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model.

François S, Mouiseddine M, Mathieu N, Semont A, Monti P, Dudoignon N, Saché A, Boutarfa A, Thierry D, Gourmelon P, Chapel A.

Ann Hematol. 2007 Jan;86(1):1-8. Epub 2006 Oct 17.

PMID:
17043780
46.

[Therapeutic effect of human mesenchymal stem cells in skin after radiation damage].

Bensidhoum M, Gobin S, Chapel A, Lemaitre G, Bouet S, Waksman G, Thierry D, Martin MT.

J Soc Biol. 2005;199(4):337-41. French.

PMID:
16738528
47.

Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.

François S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J, Saché A, Bouchet S, Thierry D, Gourmelon P, Gorin NC, Chapel A.

Stem Cells. 2006 Apr;24(4):1020-9. Epub 2005 Dec 8.

48.

[Mesenchymal stem cells from human proximal femurs possess immunosuppressive activity].

Zhang YZ, Fouillard L, Chapel A, Bensidhoum M, Mazurier C, Nasef A, Bouchet S, Lopez M, Thierry D, Gorin NC, Da WM.

Zhonghua Yi Xue Za Zhi. 2005 Oct 19;85(39):2780-4. Chinese.

PMID:
16324321
49.

Triadins are not triad-specific proteins: two new skeletal muscle triadins possibly involved in the architecture of sarcoplasmic reticulum.

Vassilopoulos S, Thevenon D, Rezgui SS, Brocard J, Chapel A, Lacampagne A, Lunardi J, Dewaard M, Marty I.

J Biol Chem. 2005 Aug 5;280(31):28601-9. Epub 2005 May 31.

50.

Application of autologous hematopoietic cell therapy to a nonhuman primate model of heterogeneous high-dose irradiation.

Bertho JM, Prat M, Frick J, Demarquay C, Gaugler MH, Dudoignon N, Clairand I, Chapel A, Gorin NC, Thierry D, Gourmelon P.

Radiat Res. 2005 May;163(5):557-70.

PMID:
15850418

Supplemental Content

Loading ...
Support Center